RxDoctor Payments Data

Jeffrey Cunningham, MD

Otolaryngology · Southaven, MSNPI 1073798781

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 60 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 40.6% of the total. That places this record below the midpoint for otolaryngology clinicians in MS, where the typical reported total is $1,327.

$1,247in general payments, 2019–2025

Across 60 payments — averaging $20.79 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$506
  • Medtronic$272
  • Intersect ENT, Inc.$136
  • Aerin Medical Inc.$83
  • Optinose US, Inc.$81
  • Stryker$68
  • plus $102 from 5 others

What the payments were for

  • Food & beverage$1,247100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,247 in reported general payments places this provider in the 45th percentile of 97 otolaryngology providers in Mississippi.

See all otolaryngology providers in Mississippi

Medicare billing

Part B allowed, 2024
$217,896
Medicare patients
995
Services billed
1,685

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Azelastine Hcl330$8,650
Ipratropium Bromide126$3,333
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort38$2,167
Famotidine227$2,044
Levocetirizine Dihydrochloride108$1,712
Amitriptyline Hcl160$1,584
Clotrimazole37$1,532
Fluocinolone Acetonide Oil38$1,396
Pantoprazole Sodium137$1,382
Tobramycin-DexamethasoneTobramycin/Dexamethasone26$1,333
Scopolamine22$1,311
SynthroidLevothyroxine Sodium25$1,271
Betamethasone Dipropionate41$948
Fluticasone Propionate95$886
Prednisone163$531

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieSynthroid$506$1,27125 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 45th percentile of 97 otolaryngology providers in Mississippi.

Other otolaryngology in Southaven

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →